Platelet function and ageing

被引:88
作者
Jones, Chris I. [1 ]
机构
[1] Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Harborne Bldg, Reading RG6 6AS, Berks, England
关键词
AGE-RELATED-CHANGES; VON-WILLEBRAND-FACTOR; THROMBUS FORMATION; ANTIPLATELET THERAPY; BONE-MARROW; INTEGRIN ALPHA(IIB)BETA(3); ENDOTHELIAL DYSFUNCTION; GLYCOPROTEIN IIB/IIIA; PHOSPHATIDIC-ACID; ADVANCING AGE;
D O I
10.1007/s00335-016-9629-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There are clear age-related changes in platelet count and function, driven by changes in hematopoietic tissue, the composition of the blood and vascular health. Platelet count remains relatively stable during middle age (25-60 years old) but falls in older people. The effect of age on platelet function is slightly less clear. The longstanding view is that platelet reactivity increases with age in an almost linear fashion. There are, however, serious limitations to the data supporting this dogma. We can conclude that platelet function increases during middle age, but little evidence exists on the changes in platelet responsiveness in old age (> 75 years old). This change in platelet function is driven by differential mRNA and microRNA expression, an increase in oxidative stress and changes in platelet receptors. These age-related changes in platelets are particularly pertinent given that thrombotic disease and use of anti-platelet drugs is much more prevalent in the elderly population, yet the majority of platelet research is carried out in young to middle-aged (20-50 years old) human volunteers and young mice (2-6 months old). We know relatively little about exactly how platelets from people over 75 years old differ from those of middle-aged subjects, and we know even less about the mechanisms that drive these changes. Addressing these gaps in our knowledge will provide substantial understanding in how cell signalling changes during ageing and will enable the development of more precise anti-platelet therapies.
引用
收藏
页码:358 / 366
页数:9
相关论文
共 83 条
  • [1] ALEVRIADOU BR, 1993, BLOOD, V81, P1263
  • [2] Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
    Andreotti, Felicita
    Rocca, Bianca
    Husted, Steen
    Ajjan, Ramzi A.
    ten Berg, Jurrien
    Cattaneo, Marco
    Collet, Jean-Philippe
    De Caterina, Raffaele
    Fox, Keith A. A.
    Halvorsen, Sigrun
    Huber, Kurt
    Hylek, Elaine M.
    Lip, Gregory Y. H.
    Montalescot, Gilles
    Morais, Joao
    Patrono, Carlo
    Verheugt, Freek W. A.
    Wallentin, Lars
    Weiss, Thomas W.
    Storey, Robert F.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (46) : 3238 - +
  • [3] Elastin-Elastases and Inflamm-Aging
    Antonicelli, Frank
    Bellon, Georges
    Debelle, Laurent
    Hornebeck, William
    [J]. CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 79, 2007, 79 : 99 - 155
  • [4] Review on Pharmacokinetics and Pharmacodynamics and the Aging Kidney
    Aymanns, Christian
    Keller, Frieder
    Maus, Sebastian
    Hartmann, Bertram
    Czock, David
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (02): : 314 - 327
  • [5] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [6] Bassareo PP, 2012, CURR PHARM DESIGN, V18, P3019
  • [7] PLATELET ACTIVITY AND PHOSPHOINOSITIDE TURNOVER INCREASE WITH ADVANCING AGE
    BASTYR, EJ
    KADROFSKE, MM
    VINIK, AI
    [J]. AMERICAN JOURNAL OF MEDICINE, 1990, 88 (06) : 601 - 606
  • [8] Bennett JS, 2001, ANN NY ACAD SCI, V936, P340
  • [9] GENERATION OF PROTHROMBIN-CONVERTING ACTIVITY AND THE EXPOSURE OF PHOSPHATIDYLSERINE AT THE OUTER SURFACE OF PLATELETS
    BEVERS, EM
    COMFURIUS, P
    VANRIJN, JLML
    HEMKER, HC
    ZWAAL, RFA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 122 (02): : 429 - 436
  • [10] The epidemiology of cardiovascular disease in the UK 2014
    Bhatnagar, Prachi
    Wickramasinghe, Kremlin
    Williams, Julianne
    Rayner, Mike
    Townsend, Nick
    [J]. HEART, 2015, 101 (15) : 1182 - 1189